Lilly Appeals $183M False Claims Hit, Sees New RICO Suit for Bladder Cancer Drug

Eli Lilly has filed an appeal to the U.S. Court of Appeals for the Seventh Circuit following a May 9 decision that it violated the False Claims Act by underpaying rebates to Medicaid.
Source: Drug Industry Daily